Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mesa

Showing results (21-30 of 472) with videos related to

Pageof 48
Sort By:
Blood|June 6, 2009
Itchy mast cells in MPNsRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|December 5, 2017
New guidelines from the NCCN for polycythemia veraRuben A Mesa
International Journal of Hematology|November 15, 2002
The therapy of myelofibrosis: targeting pathogenesisRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|April 12, 2017
The new NCCN guidelines for the management of myelofibrosisRuben A Mesa
Blood|November 30, 2013
Clearing the path for MPN therapy monitoringRuben A Mesa
Current Hematologic Malignancy Reports|April 29, 2010
New drugs for the treatment of myelofibrosisRuben A Mesa
Leukemia Research|April 26, 2011
Transplantation for myelofibrosis: time for a randomized trialRuben A Mesa
Leukemia & Lymphoma|July 17, 2012
The evolving treatment paradigm in myelofibrosisRuben A Mesa
JCO Oncology Practice|July 11, 2020
How and When to Manage Ruxolitinib Failure in MyelofibrosisRuben A Mesa
Anesthesia and Analgesia|April 27, 2000
Hidden damage to a reinforced LMA-Fastrach endotracheal tubeA Mesa, R Miguel
Pageof 48

Showing results (21-30 of 472) with videos related to

Sort By:
Pageof 48
Blood|June 6, 2009
Itchy mast cells in MPNsRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|December 5, 2017
New guidelines from the NCCN for polycythemia veraRuben A Mesa
International Journal of Hematology|November 15, 2002
The therapy of myelofibrosis: targeting pathogenesisRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|April 12, 2017
The new NCCN guidelines for the management of myelofibrosisRuben A Mesa
Blood|November 30, 2013
Clearing the path for MPN therapy monitoringRuben A Mesa
Current Hematologic Malignancy Reports|April 29, 2010
New drugs for the treatment of myelofibrosisRuben A Mesa
Leukemia Research|April 26, 2011
Transplantation for myelofibrosis: time for a randomized trialRuben A Mesa
Leukemia & Lymphoma|July 17, 2012
The evolving treatment paradigm in myelofibrosisRuben A Mesa
JCO Oncology Practice|July 11, 2020
How and When to Manage Ruxolitinib Failure in MyelofibrosisRuben A Mesa
Anesthesia and Analgesia|April 27, 2000
Hidden damage to a reinforced LMA-Fastrach endotracheal tubeA Mesa, R Miguel
Pageof 48